Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human C1 inhibitor for acute hereditary angioedema attacks
2005-000206-31Phase 3Completed
- Sponsor
- Pharming Group
- Start
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hereditary angioedema (HAE) comparing Recombinant human C1 inhibitor with Placebo (2 arms). Started Oct 2007; status: completed.
02
Drugs
conestat alfa
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on 2005-000206-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000206-31.